Zn(2+)/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
No detected effect on necrotising enterocolitis incidence
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull result“Enteral zinc supplementation may have little or no effect on common morbidities such as bronchopulmonary dysplasia (RR 0.66, 95% CI 0.31 to 1.40, 1 study, 193 infants; low-certainty evidence), retinopathy of prematurity (RR 0.14, 95% CI 0.01 to 2.70, 1 study, 193 infants; low-certainty evidence), bacterial sepsis (RR 1.11, 95% CI 0.60 to 2.04, 2 studies, 293 infants; moderate-certainty evidence), or necrotising enterocolitis (RR 0.08, 95% CI 0.00 to 1.33, 1 study, 193 infants; low-certainty evidence).”
Quoted verbatim from Enteral zinc supplementation for prevention of morbidity and mortality in preterm neonates.. - Study
- meta-analysis
- Participants
- 193
- Population
- Hospitalised preterm infants given enteral zinc versus placebo or no supplementation; single study
Effect 0.08 risk ratio, 95% CI 0 to 1.33
Enteral zinc supplementation for prevention of morbidity and mortality in preterm neonates.2021PMID:33710626Permalink
Keep reading
- Everything the graph holds on Zn(2+)
- Every compound studied against Necrotising enterocolitis incidence
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M4QHR813NHKY6C6Q45Y8NX01